BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36968967)

  • 1. Excess Mortality Associated With Loiasis: Confirmation by a New Retrospective Cohort Study Conducted in the Republic of Congo.
    Hemilembolo MC; Niama AC; Campillo JT; Pion SD; Missamou F; Whittaker C; Kankou JM; Ndziessi G; Bileckot RR; Boussinesq M; Chesnais CB
    Open Forum Infect Dis; 2023 Mar; 10(3):ofad103. PubMed ID: 36968967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excess mortality associated with loiasis: a retrospective population-based cohort study.
    Chesnais CB; Takougang I; Paguélé M; Pion SD; Boussinesq M
    Lancet Infect Dis; 2017 Jan; 17(1):108-116. PubMed ID: 27777031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between arterial stiffness and Loa loa microfilaremia in a rural area of the Republic of Congo: A population-based cross-sectional study (the MorLo project).
    Campillo JT; Dupasquier V; Lebredonchel E; Rancé LG; Hemilembolo MC; Pion SDS; Boussinesq M; Missamou F; Perez Martin A; Chesnais CB
    PLoS Negl Trop Dis; 2024 Jan; 18(1):e0011915. PubMed ID: 38241411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loa loa and Mansonella perstans microfilaremia in the department of Lékoumou, Republic of Congo.
    Hemilembolo MC; Campillo JT; Niama AC; Pion SDS; Missamou F; Boussinesq M; Bileckot RR; Chesnais CB
    Parasit Vectors; 2023 Dec; 16(1):451. PubMed ID: 38071391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between altered cognition and Loa loa microfilaremia: First evidence from a cross-sectional study in a rural area of the Republic of Congo.
    Checkouri T; Missamou F; Pion SDS; Bikita P; Hemilembolo MC; Boussinesq M; Chesnais CB; Campillo JT
    PLoS Negl Trop Dis; 2023 Jun; 17(6):e0011430. PubMed ID: 37339123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Filarial antigenemia and Loa loa night blood microfilaremia in an area without bancroftian filariasis in the Democratic Republic of Congo.
    Bakajika DK; Nigo MM; Lotsima JP; Masikini GA; Fischer K; Lloyd MM; Weil GJ; Fischer PU
    Am J Trop Med Hyg; 2014 Dec; 91(6):1142-1148. PubMed ID: 25223938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of diagnostic test outcomes in a large loiasis cohort from an endemic region: Serological tests are often false negative in hyper-microfilaremic infections.
    Veletzky L; Eberhardt KA; Hergeth J; Stelzl DR; Zoleko Manego R; Kreuzmair R; Burger G; Mischlinger J; McCall MBB; Mombo-Ngoma G; Adegnika AA; Agnandji ST; Matsiegui PB; Lell B; Kremsner P; Mordmüller B; Tappe D; Ramharter M
    PLoS Negl Trop Dis; 2024 Mar; 18(3):e0012054. PubMed ID: 38484012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with the periodicity of Loa loa microfilaremia in the Republic of the Congo.
    Campillo JT; Louya F; Bikita P; Missamou F; Pion SDS; Boussinesq M; Chesnais CB
    Parasit Vectors; 2022 Nov; 15(1):417. PubMed ID: 36352480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
    Wanji S; Chounna Ndongmo WP; Fombad FF; Kengne-Ouafo JA; Njouendou AJ; Longang Tchounkeu YF; Koudou B; Bockarie M; Fobi G; Roungou JB; Enyong PA
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006750. PubMed ID: 30226900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reliability evaluation in rural Congo of the calibrated blood smear technique to assess
    Campillo JT; Louya F; Bikita P; Missamou F; Boussinesq M; Pion SDS; Bertout S; Chesnais CB
    Med Trop Sante Int; 2023 Mar; 3(1):. PubMed ID: 37389374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and intensity of Loa loa infection over twenty-three years in three communities of the Mbalmayo health district (Central Cameroon).
    Mogoung-Wafo AE; Nana-Djeunga HC; Domche A; Fossuo-Thotchum F; Bopda J; Mbickmen-Tchana S; Djomo-Kamga H; Kamgno J
    BMC Infect Dis; 2019 Feb; 19(1):146. PubMed ID: 30760228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a surface antigen on Loa loa microfilariae the recognition of which correlates with the amicrofilaremic state in man.
    Pinder M; Dupont A; Egwang TG
    J Immunol; 1988 Oct; 141(7):2480-6. PubMed ID: 3049808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A call for loiasis to be added to the WHO list of neglected tropical diseases.
    Jacobsen KH; Andress BC; Bhagwat EA; Bryant CA; Chandrapu VR; Desmonts CG; Matthews TM; Ogunkoya A; Wheeler TJ; Williams AS
    Lancet Infect Dis; 2022 Oct; 22(10):e299-e302. PubMed ID: 35500592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loa loa vectors Chrysops spp.: perspectives on research, distribution, bionomics, and implications for elimination of lymphatic filariasis and onchocerciasis.
    Kelly-Hope L; Paulo R; Thomas B; Brito M; Unnasch TR; Molyneux D
    Parasit Vectors; 2017 Apr; 10(1):172. PubMed ID: 28381279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG4 serology of loiasis in three villages in an endemic area of south-eastern Gabon.
    Touré FS; Egwang TG; Millet P; Bain O; Georges AJ; Wahl G
    Trop Med Int Health; 1998 Apr; 3(4):313-7. PubMed ID: 9623933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between blood Loa loa microfilarial density and proteinuria levels in a rural area of the Republic of Congo (the MorLo project): a population-based cross-sectional study.
    Campillo JT; Hemilembolo MC; Pion SDS; Lebredonchel E; Dupasquier V; Boullé C; Rancé LG; Boussinesq M; Missamou F; Chesnais CB
    Lancet Microbe; 2023 Sep; 4(9):e704-e710. PubMed ID: 37480932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of parasite-specific IgG4 in the absence of microfilaremia in Loa loa infection.
    Akue JP; Egwang TG; Devaney E
    Trop Med Parasitol; 1994 Sep; 45(3):246-8. PubMed ID: 7899797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.
    Kamgno J; Pion SD; Chesnais CB; Bakalar MH; D'Ambrosio MV; Mackenzie CD; Nana-Djeunga HC; Gounoue-Kamkumo R; Njitchouang GR; Nwane P; Tchatchueng-Mbouga JB; Wanji S; Stolk WA; Fletcher DA; Klion AD; Nutman TB; Boussinesq M
    N Engl J Med; 2017 Nov; 377(21):2044-2052. PubMed ID: 29116890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using Community-Level Prevalence of Loa loa Infection to Predict the Proportion of Highly-Infected Individuals: Statistical Modelling to Support Lymphatic Filariasis and Onchocerciasis Elimination Programs.
    Schlüter DK; Ndeffo-Mbah ML; Takougang I; Ukety T; Wanji S; Galvani AP; Diggle PJ
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005157. PubMed ID: 27906982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial Aggregation and Heritability of Loa loa Microfilaremia.
    Eyebe S; Sabbagh A; Pion SD; Nana-Djeunga HC; Kamgno J; Boussinesq M; Chesnais CB
    Clin Infect Dis; 2018 Feb; 66(5):751-757. PubMed ID: 29040446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.